Novo’s Higher-Dose GLP-1, Dexcom & Medtronic CGM Updates, and “TIR” Debate | Newsy News #5

Get the latest diabetes news in this video. Dr. Steve Edelman and Dr. Jeremy Pettus break down Novo Nordisk’s higher semaglutide dose (Wegovy), fresh CGM updates from Dexcom and Medtronic, and whether “Time in Tight Range” (70–140 mg/dL) should replace standard TIR. The TCOYD team will answer questions like: “Is a 7.2mg dose of Wegovy the future of weight loss?” And “Is "Time in Tight Range" the new goal for CGM users?” This is your must-watch video for current diabetes information with a little humor on the side! What You’ll Learn: Wegovy 7.2 mg trial: what a higher GLP-1 dose could mean Dexcom sensor life extension & Medtronic Simplera FDA approval Time in Range vs Time in Tight Range Handling unsolicited advice like a pro Both Dr. Edelman and Dr. Pettus are endocrinologists who have lived with type 1 diabetes since age 15. They bring you trustworthy diabetes information that is educational and entertaining! ✨ Subscribe for must-know updates, advocacy news, and technology breakthroughs that empower people with diabetes to live longer, healthier, and happier lives. Let's stay informed and take control together! We've got tons of other great resources on how to live a long and healthy life with diabetes: Website: https://tcoyd.org Blog: https://tcoyd.org/blog/ Podcast: https://tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly e-newsletter here: https://tcoyd.org/newsletter-subscribe/ Please consider helping TCOYD continue to improve the lives of those living with diabetes by supporting our educational programs: https://tcoyd.org/donate Timecodes: 0:00 - Intro 0:22 - Ozempic/Wegovy higher-dose information 1:54 - CGM news roundup 2:01 - Dexcom sensor life extension 2:09 -Medtronic Simplera FDA approval 3:03 - Time in Range (70–180) vs Time in Tight Range (70–140) 4:42 - How to handle “Diabetes Know-It-Allism” 5:45 - Takeaways & what to watch next #DiabetesNews #CGMupdates #TimeInRange